Conforma Therapeutics Corporation: Targeting Heat Shock Protein To Fight Cancer
10/19/2005 5:10:15 PM
May 11, 2005 -- Last week, Conforma Therapeutics Corp. of San Diego, CA, added $11 million to its war chest to pursue small molecule drugs against the heat shock proteins in the Hsp90 family, a novel target family in oncology. Heat shock proteins, which were discovered during sudden application of heat, are cellular chaperones, or proteins that guide other proteins during folding or conformation. We look at the science and the expertise of this promising area of cancer therapeutics...
comments powered by